b'8.83%IMPROVEMENT SINCE INTAKE 31.09%IMPROVEMENT SINCE INTAKE 65.02%IMPROVEMENT SINCE INTAKE.45%IMPROVEMENT SINCE INTAKE13.93%IMPROVEMENT SINCE INTAKE\x1c \x1e \x1c\x07 \x19\x1b\x07 \x1c\x19 \x02 \x0b \x1c\x19 \x0b \x0c \x04 \x19 \x1f \x1b \x19 \x1a \x1b\x05 \x0b \x1f \x1b \x1a \x19 \x16 \x08\x10\x11 \x17\x15 \x13\x1c\x15\x14 \x1a \x12 \x1f \x1b\x1e\x11 \x1d\x1b\x11 \x1d\x15\x19\x15\x1c \x0e \x15\x11 \x12 \x0f \x1d\x1c \x1e \x1e\x19\x1d \x16\x1b\x0c\x1b \x1f \x0c \x1d\x13\x11 \x14 \x1d\x13 \x0c \x0c\x1e \x12\x1b\x13\x1f \x15\x14\x1d\x12 \x1e \x0c \x1f \x0c\x1d\x1f\x1e\x1d\x17 \x1e\x0c\x18\x1b \x1f\x13\x0b \x0c\x16 \x12 \x16\x14 \x13 \x13 \x11 \x17 \x13\x0f \x18 \x16 \x18 \x12 \x17 \x16 \x16\x12 \x18 \x18HIV WEEKLY AVERAGE AVERAGE WEEKLYDIAGNOSIS SYPHILIS DIAGNOSIS CURRENT PRIMARY CURE AVERAGENEW PATIENTS AND TREATMENT CARE CENTERS HEPATITIS C BLOOD DRAW WEEKLY VISITS MEDICATION TO HEPATITIS CPATIENTS REACTIVE PATIENTS ENROLLED INPRESCRIBED HEPATITIS C PRIMARY CARE SERVICESpage10'